Dr. John Dick, Senior Scientist at the Ontario Cancer Institute, the research arm of Princess Margaret Hospital, co-led a multinational team that has developed the first leukemia therapy that targets a protein, CD123, on the surface of cancer stem cells that drive acute myeloid leukemia (AML), which is an aggressive disease with a poor outcome.
Full article >>
Monday, July 6, 2009
New discovery points to a new treatment avenue for acute myeloid leukemia
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment